Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03004183
Title SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jenny C. Chang, MD
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

Pembrolizumab

AdV-tk + Valacyclovir

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.